MINNEAPOLIS– Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of managing director and senior research analyst, Dave Westenberg. He will cover the life science tools & diagnostics sector.
Prior to joining Piper Sandler, Westenberg was a senior equity research analyst at Guggenheim Partners where he covered the tools and omics and animal health sectors. He brings 8+ years of sector coverage and worked in the life sciences industry earlier in his career. Westenberg received a B.S. in Business Administration from San Francisco State University and a Masters, Finance from Università Bocconi in Italy.
“We remain impressed by the caliber of individuals choosing to join the Piper Sandler equity research team and we are excited to welcome Dave to our growing Healthcare platform. The Life Science Tools & Diagnostics sector is experiencing rapid growth and technological innovation, which is increasing the sector’s strategic importance to the global Healthcare landscape,” said Michael Cox, co-head of global equities at Piper Sandler.
